Lung disease due to α1-antitrypsin deficiency

Current Opinion in Pulmonary Medicine

Volumn 2, Issue 2, 1996, Pages 155-160

  Wiedemann, Herbert P ^a   Stoller, James K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN;

AIRWAY OBSTRUCTION; ALPHA 1 ANTITRYPSIN DEFICIENCY; BLOOD; GENETICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; LUNG; LUNG ALVEOLUS; LUNG EMPHYSEMA; METABOLISM; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SURVIVAL RATE;

AIRWAY OBSTRUCTION; ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; HUMANS; INFUSIONS, INTRAVENOUS; LUNG; PULMONARY ALVEOLI; PULMONARY EMPHYSEMA; RISK FACTORS; SURVIVAL RATE;

EID: 0030089958     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-199603000-00013     Document Type: Article

References (44)

1. Laurell CB, Eriksson S: The electrophoretic alpha 1-globulin pattern of serum in alpha 1-antitrypsin deficiency. Scand J Clin Lab Invest 1963, 15:132-140.
2. Eriksson S: Pulmonary emphysema and alpha 1-antitrypsin deficiency. Acta Med Scand 1964, 175:197-205.
3. Lieberman J, Winter B, Sastre A: Alpha 1-antitrypsin PI-types in 965 COPD patients. Chest 1986, 89:370-373.
4. 1-antitrypsin deficiency are provided, based upon the most up-to-date information currently available.
5. Rovner MS, Stoller JK: Therapy for alpha 1-antitrypsin deficiency. Clin Pulm Med 1994, 1:135-143.
6. Stoller JK: Clinical manifestations of alpha 1-antitrypsin deficiency [CD-ROM]. UpToDate in Pulmonary and Critical Care Medicine. American Thoracic Society: in press.
7. Rovner MS, Stoller JK: Therapy for Alpha 1-Antitrypsin Deficiency [CD-ROM]. UpToDate in Pulmonary and Critical Care Medicine. American Thoracic Society: in press.
8. Crystal RG: Alpha 1-antitrypsin deficiency: pathogenesis and treatment. Hosp Prac 1991, 2:81-94.
9. Brantly M, Nukiwa T, Crystal RG: Molecular basis of alpha 1-antitrypsin deficiency. Am J Med 1988, 84(suppl 6A): 13-31.
10. Eriksson S, Carlson J, Velez R: Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. N Engl J Med 1986, 314:736-739.
11. Sveger T: Liver disease in alpha 1-antitrypsin deficiency detected by screening of 200,000 infants. N Engl J Med 1976, 294:1316-1321.
12. Brantly ML, Paul LD, Miller BH, Falk BH, Wu M, Crystal RG: Clinical features and history of the destructive lung disease associated with alpha 1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis 1988, 138:327-336.
13. Silverman EK, Pierce JA, Province MA, Rao DC, Campbell EJ: Variability of pulmonary function in alpha 1-antitrypsin deficiency, clinical correlates. Ann Intern Med 1989, 11:982-991.
14. Larsson C: Natural history and life expectancy in severe alpha 1-antitrypsin deficiency. PI*Z. Acta Med Scand 1978, 204:345-356.
15. Tobin MJ, Cook PJL, Hutchinson DCS: Alpha 1-antitrypsin deficiency: The clinical and physiological features of pulmonary emphysema in subjects homozygous for PI-type Z: a survey by the British Thoracic Association. Br J Dis Chest 1983, 77:14-27.
16. Janus ED, Phillips NT, Carrell RW: Smoking, lung function, and alpha 1-antitrypsin deficiency. Lancer 1985, 1:152-154.
17. Hutchison DCS, Tobin MJ, Cooper D, Lowe D: Longitudinal studies in alpha 1-antitrypsin deficiency: a survey by the British Thoracic Society. In Pulmonary Emphysema and Proteolysis. Edited by Taylor JC, Mittman C. New York: Academic Press; 1987:7-15.
18. Wu MC, Eriksson S: Lung function, smoking, and survival in severe alpha 1-antitrypsin deficiency, PI*ZZ. J Clin Epidemiol 1988, 41:1157-1165.
19. Buist AS, Burrows B, Eriksson S, Mittman C, Wu M: The natural history of air-flow obstruction in PI*Z emphysema: report of an NHLBI workshop. Am Rev Respir Dis 1983, 127(suppl):S43-S50.
20. 1 and mortality) will be reported in mid 1996.
21. Viskum K, Kok-Jensen A: Criteria for alpha 1-antitrypsin substitution. Lung 1990, 168(suppl 1):586-591.
22. Seersholm N, Kok-Jensen A, Dirksen A: Survival of patients with severe alpha 1-antitrypsin deficiency with special reference to non-index cases. Thorax 1994, 49:695-698.
23. 1-antitrypsin deficiency does not generally prevent normal lung maturation or cause early disease.
24. Gishen P, Saunders AJS, Tobin MJ, Hutchison DCS: Alpha 1-antitrypsin deficiency: the radiological features of pulmonary emphysema in subjects of PI-type Z and PI-type SZ. A survey by the British Thoracic Association. Clin Radiol 1982, 33:371-377.
25. Townley RG, Southard JG, Radford P, Hopp RJ, Bewtra AK, Ford L: Association of MS Pi phenotype with airway hyperresponsiveness. Chest 1990, 98:594-599.
26. Colp C, Pappas J, Moran D, Lieberman J: Variants of alpha 1-antitrypsin in Puerto Rican children with asthma. Chest 1993, 103:812-815.
27. Gadek JE, Klein HG, Holland PV, Crystal RG: Replacement therapy of alpha 1-antitrypsin deficiency. J Clin Invest 1981, 68:1158-1165.
28. Wewers MD, Casolaro MA, Sellers SE, Swayze SC, McPhaul KM, Wittes JT, Crystal RG: Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema. N Engl J Med 1987, 316:1055-1062.
29. Snider GL, Stone, PJ, Morris TA, Franzblau C: Evidence that augmentation therapy diminishes degradation of cross-linked elastin in alpha 1-antitrypsin deficient humans. Am Rev Respir Dis 1993, 147:A674.
30. American Thoracic Society: Guidelines for the approach to the patient with severe hereditary alpha 1-antitrypsin deficiency. Am Rev Respir Dis 1989, 27:1494-1497.
31. Canadian Thoracic Society: Current status of alpha 1-antitrypsin replacement therapy: recommendations for the management of patients with severe hereditary deficiency. Can Med Assoc J 1992, 146:841-844.
32. Hubbard RC, Sellers S, Czerski D, Stephens L, Crystal RG: Biochemical efficacy and safety of monthly augmentation therapy for alpha 1-antitrypsin deficiency. JAMA 1988, 260:1259-1264.
33. Caughey GH: Should alpha 1-antitrypsin-deficient patients with emphysema continue to receive alpha 1-antitrypsin after lung transplantation? J Heart Lung Transplant 1993, 12:708-709.
34. King MB, Campbell EJ, Gray BH, Hertz MI: The protease-antiprotease balance in alpha 1-antiprotease inhibitor-deficient lung transplant recipients. Am J Resp Crit Care Med 1994, 149(4 pt 1): 966-971.
35. Mast AE, Salversen AE, Schnebli HP, Pizzo SV: Evaluation of the rapid plasma elimination of recombinant alpha 1-proteinase inhibitor: synthesis of polyethylene glycol conjugates with improved therapeutic potential. J Lab Clin Med 1990, 116:58-65.
36. Hubbard RC, McElvaney NG, Sellers SE, Healy JT, Czerski DB, Crystal RG: Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract anti-neutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency. J Clin Invest 1989, 84:1349-1354.
37. Hubbard RC, Brantly ML, Sellers SE, Mitchell ME, Crystal RG: Anti-neutrophil elastase defenses of the lower respiratory tract in alpha 1-antitrypsin deficiency directly augmented with an aerosol of alpha 1-antitrypsin. Ann Intern Med 1989, 111:206-212.
38. Hubbard RC, Crystal RG: Strategies for aerosol therapy of alpha 1-antitrypsin deficiency by the aerosol route. Lung 1990, 168(suppl):565-578.
39. Kay MA, Baley P, Rothenberg S, Leland F, Fleming L, Ponder KP, et al.: Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes. Proc Natl Acad Sci 1992, 89:89-93.
40. Rosenfeld MA, Siegfried W, Yoshimura K, Yoneyama K, Fukoyama M, Steer LE, et al.: Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science 1991, 252:431-434.
41. LeMarchand P, Jaffe HA, Donel C, Cid MC, Kleinman HK, Perricaudet LD, et al.: Adenovirus-mediated transfer of a recombinant human alpha 1-antitrypsin cDNA to human endothelial cells. Proc Natl Acad Sci 1992, 89:6482-6486.
42. Setoguchi Y, Jaffe HA, Chu CS, Crystal RG: Intraperitioneal in vivo gene therapy to deliver alpha 1-antitrypsin to the systemic circulation. Am J Respir Cell Mol Biol 1994, 10:369-377.
43. Canonico AE, Conary JT, Meyrick BO, Brigham KL: Aerosol and intravenous transfection of human alpha 1-antitrypsin gene to lung of rabbits. Am J Respir Cell Mol Biol 1994, 10:24-29.
44. 1-antitrypsin deficiency. Other published data on this issue have been somewhat limited and contradictory.